4.6 Article

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

Georg Semmler et al.

Summary: This study confirms the predictive value of noninvasive markers (LSM and VITRO) in determining the development of hepatic decompensation and hepatocellular carcinoma in patients with chronic liver disease caused by hepatitis C after cure. By combining these markers, it is possible to more accurately identify the risk of hepatic decompensation in patients in the future.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery

Patrick Starlinger et al.

Summary: Perioperative intake of SSRIs/SNRIs is significantly associated with adverse postoperative outcomes after hepatic resection, indicating that these drugs should be avoided in patients undergoing liver resections.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Acute kidney injury is associate d with increase d levels of circulating microvesicles in patients with decompensated cirrhosis

Elena Campello et al.

Summary: This study characterized the circulating plasma microvesicles (MVs) in patients with decompensated cirrhosis and acute kidney injury (AKI), and found that AKI worsens vascular and cellular homeostasis, particularly by inducing endothelial dysfunction and platelet activation.

DIGESTIVE AND LIVER DISEASE (2021)

Article Gastroenterology & Hepatology

Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure-Related Bleeding in Decompensated Cirrhosis

Alberto Zanetto et al.

Summary: TEG is a useful tool in predicting procedure-related bleeding risk in patients with decompensated cirrhosis, particularly with a TEG MA < 30mm indicating high risk for major bleeding. Traditional coagulation tests were not effective in distinguishing between bleeding and non-bleeding patients.

HEPATOLOGY COMMUNICATIONS (2021)

Article Cardiac & Cardiovascular Systems

Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer

Takumi Toya et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)

Review Gastroenterology & Hepatology

Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis

Maxime G. Zermatten et al.

HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection

Teng-Yu Lee et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Medicine, General & Internal

Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality

Tracey G. Simon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Hematology

Von Willebrand factor and cancer; metastasis and coagulopathies

Sean Patmore et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Gastroenterology & Hepatology

Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma

Po-Hong Liu et al.

LIVER INTERNATIONAL (2020)

Article Biochemistry & Molecular Biology

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Mohsen Malehmir et al.

NATURE MEDICINE (2019)

Review Oncology

Platelets as Key Factors in Hepatocellular Carcinoma

Natasa Pavlovic et al.

CANCERS (2019)

Article Medical Laboratory Technology

Platelet activation status in the diagnosis and postoperative prognosis of hepatocellular carcinoma

Beili Wang et al.

CLINICA CHIMICA ACTA (2019)

Article Cell Biology

The role of coagulation and platelets in colon cancer-associated thrombosis

Annachiara Mitrugno et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)

Article Gastroenterology & Hepatology

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis

Stefaia Basin et al.

HEPATOLOGY COMMUNICATIONS (2019)

Article Hematology

Emerging Roles for von Willebrand Factor in Cancer Cell Biology

Jamie M. O'Sullivan et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals

Francesco Paolo Russo et al.

LIVER INTERNATIONAL (2018)

Editorial Material Gastroenterology & Hepatology

The Cirrhotic Platelet: Shedding Light on an Enigma

Stephen Caldwell et al.

HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Low-Grade Endotoxemia and Platelet Activation in Cirrhosis

Valeria Raparelli et al.

HEPATOLOGY (2017)

Review Gastroenterology & Hepatology

Thrombocytopenia in chronic liver disease

Markus Peck-Radosavljevic

LIVER INTERNATIONAL (2017)

Article Gastroenterology & Hepatology

Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans

Robin Padickakudy et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma

Alberto Zanetto et al.

DIGESTIVE AND LIVER DISEASE (2017)

Review Hematology

von Willebrand factor, Jedi knight of the bloodstream

Timothy A. Springer

BLOOD (2014)

Review Oncology

Platelets Effects on Tumor Growth

Hadi A. Goubran et al.

SEMINARS IN ONCOLOGY (2014)

Review Hematology

Coagulation and cancer: biological and clinical aspects

A. Falanga et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)

Article Hematology

Platelets increase the proliferation of ovarian cancer cells

Min Soon Cho et al.

BLOOD (2012)

Article Medicine, General & Internal

Paraneoplastic Thrombocytosis in Ovarian Cancer

Rebecca L. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B

Giovanni Sitia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Gastroenterology & Hepatology

Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?

F. Violi et al.

JOURNAL OF HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma

Shinn-Jang Hwang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2004)